Eighty randomised trials enrolling 29,861 people sit behind the latest edition of the Cochrane living review on electronic ...
- OKX secured a $25B valuation via a funding round led by existing suppliers (Circle, Ripple, Standard Chartered, QRT), maintaining flat pricing to solidify control over business flows.